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Introduction. Pulmonary vein isolation is an established therapy for symptomatic atrial 
fibrillation (AF). The second generation cryoballoon is effective in achieving pulmonary vein 
isolation. In 2018 we implemented the cryoballoon ablation (CBA) in Republic of Moldova.  
Aim of the study. To assess the freedom from AF recurrence after CBA.  
Materials and methods. A retrospective study was performed in 8 consecutive patients who 
underwent CBA using Arctic Front Advance cryoballoon (Medtronic) for paroxysmal or 
persistent AF from June 2018 till December 2019 in Medpark International Hospital. We 
followed up the patients from June 2018 till March 2020. The information about the clinical 
symptoms and ECG data during follow-up was collected to identify the presence of recurrence. 
A recurrence after CBA was considered AF episode that lasted at least 30 seconds. Continuous 
variables are presented as mean ± SD. Kaplan–Meier analysis was used to determine the 
probability of freedom from AF during follow-up.  
Results. A total number of 8 patients with a mean age of 60.13 ± 6.88 years with paroxysmal 
(n=7; 87.5%) or persistent (n=1; 12.5%) AF were identified. There were 6 males (75%) and 2 
females (25%). All patients had a successful pulmonary vein isolation procedure with 100% of 
veins isolated. No patient had complication during procedure as phrenic nerve palsy, stroke or 
pericardial effusion. After a 3-month blanking period during a mean follow-up of 337 ± 135 
days there were 2 (25%) AF recurrences. One patient developed atrial flutter but not AF in the 
follow-up period with restoration of sinus rhythm with electrical cardioversion. The average 
days before recurrence was 120.5 ± 41.72 (150 and 90). Freedom from AF recurrence was 75% 
at 11,2 months follow-up.  
Conclusions. The second generation cryoballoon ablation is an effective method of treatment 
for atrial fibrillation. Our results are compatible with the success rate that is reported by 
majority of the studies.  
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Background. Acromegaly is a rare endocrine disorder that carries a significant burden of 
cardiovascular morbidity and mortality. Abnormalities of the growth hormone/insulin-like 
growth factor-1 (IGF-1) axis in acromegaly lead to the characteristic cardiovascular 
